Guru Ownership Trend
Guru Analysis for Atea Pharmaceuticals, Inc. (AVIR)
Atea Pharmaceuticals, Inc. (AVIR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.22 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $351,631.75 net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 222.5%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 1.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Atea Pharmaceuticals, Inc. (AVIR)
Major holders include Renaissance Technologies (RenTech) ($6.28 M), Steven Cohen ($643,195), Cliff Asness ($248,067). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.33 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $351,631.75, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited AVIR. The total reported sell value was $118,898.
Yes, 0 managers opened new positions in AVIR, and 2 increased their existing holdings. The total reported buy value was $470,529.75.